148 related articles for article (PubMed ID: 30279967)
21. New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.
Perrino E; Cappelletti G; Tazzari V; Giavini E; Del Soldato P; Sparatore A
Bioorg Med Chem Lett; 2008 Mar; 18(6):1893-7. PubMed ID: 18294844
[TBL] [Abstract][Full Text] [Related]
22. Isoliquiritigenin inhibits TNF-α-induced release of high-mobility group box 1 through activation of HDAC in human intestinal epithelial HT-29 cells.
Chi JH; Seo GS; Cheon JH; Lee SH
Eur J Pharmacol; 2017 Feb; 796():101-109. PubMed ID: 28012970
[TBL] [Abstract][Full Text] [Related]
23. Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model.
Cetinkaya M; Cansev M; Cekmez F; Tayman C; Canpolat FE; Kafa IM; Yaylagul EO; Kramer BW; Sarici SU
PLoS One; 2015; 10(5):e0126028. PubMed ID: 25938838
[TBL] [Abstract][Full Text] [Related]
24. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines.
Estrada-Pérez AR; García-Vázquez JB; Mendoza-Figueroa HL; Rosales-Hernández MC; Fernández-Pomares C; Correa-Basurto J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833990
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
26. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid attenuates acute lung injury induced by ischemia-reperfusion in rats.
Wu SY; Tang SE; Ko FC; Wu GC; Huang KL; Chu SJ
Anesthesiology; 2015 Jun; 122(6):1327-37. PubMed ID: 25749053
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives.
Eyal S; Yagen B; Shimshoni J; Bialer M
Biochem Pharmacol; 2005 May; 69(10):1501-8. PubMed ID: 15857614
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
[TBL] [Abstract][Full Text] [Related]
30. HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice.
Scholz B; Schulte JS; Hamer S; Himmler K; Pluteanu F; Seidl MD; Stein J; Wardelmann E; Hammer E; Völker U; Müller FU
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007071. PubMed ID: 30879335
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines.
Barciszewska AM; Belter A; Gawrońska I; Giel-Pietraszuk M; Naskręt-Barciszewska MZ
Front Oncol; 2022; 12():1033035. PubMed ID: 36465345
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes.
Fu S; Wang J; Hu X; Zhou RR; Fu Y; Tang D; Kang R; Huang Y; Sun L; Li N; Fan XG
Mol Oncol; 2018 Mar; 12(3):322-338. PubMed ID: 29316268
[TBL] [Abstract][Full Text] [Related]
33. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
34. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
[TBL] [Abstract][Full Text] [Related]
36. The activity of antiepileptic drugs as histone deacetylase inhibitors.
Eyal S; Yagen B; Sobol E; Altschuler Y; Shmuel M; Bialer M
Epilepsia; 2004 Jul; 45(7):737-44. PubMed ID: 15230695
[TBL] [Abstract][Full Text] [Related]
37. PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation.
Yang Z; Li L; Chen L; Yuan W; Dong L; Zhang Y; Wu H; Wang C
J Immunol; 2014 Dec; 193(12):6114-23. PubMed ID: 25392528
[TBL] [Abstract][Full Text] [Related]
38. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
39. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells.
Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
Abaza MS; Bahman AM; Al-Attiyah RJ
Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
